Trial: 201910139

PHASE II STUDY OF CABOZANTINIB IN COMINATION WITH NIVOLUMAB AND IPILIMUMAB IN RARE GENITOURINARY TUMORS

Phase

II

Principal Investigator

Picus, Joel

Disease Site

Kidney; Other Male Genital; Prostate; Urinary Bladder

Learn more about this study at: clinicaltrials.gov